New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 21, 2014
11:30 EDTCNC, MOH, WLP, CI, ESRXAnalyst sees Express Scripts benefiting from WellPoint member growth
After health insurer WellPoint (WLP) estimated that the number of people using its health insurance would rise by 1M-1.3M this year, Citigroup expects Express scripts to benefit from the increase. WHAT'S NEW: WellPoint announced that it expects its medical member base to rise by 1M-1.3M in 2014. The company also increased its 2014 earnings per share guidance to at least $8.20 per share, up from $8. In a note to investors earlier today, Citigroup analyst Garen Sarafian wrote that WellPoint had increased the outlook for its medical membership base from previous levels and that the insurer now predicts that the number of its medical members will rise by 3%-4% in 2014. Express Scripts, which provides pharmacy benefit management services for WellPoint, obtained over 12% of its 2013 revenue from WellPoint, the analyst stated. WellPoint's stronger than expected growth could lift Express Script's 2014 earnings per share by up to 7c, wrote Sarafian. He kept a $92 price target and Buy rating on Express Script. PRICE ACTION: In late morning trading, Express Scripts lost 0,4% to $77.65 and WellPoint added 0.7% to $100.45. WHAT'S NOTABLE: Other health insurers are rising in the wake of WellPoint's announcement, with Centene (CNC), Cigna (CI), and Molina (MOH) all higher by about 1%.
News For ESRX;WLP;CNC;CI;MOH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
December 22, 2014
07:07 EDTESRXExpress Scripts and AbbVie to expand access to Viekira Pak
Subscribe for More Information
06:39 EDTESRXHepatitis C deal a blow to biotech bull market, The Street's Feuerstein says
Subscribe for More Information
06:29 EDTESRXGilead drops 4% after Express Scripts picks AbbVie for hepatitis C
Shares of Gilead (GILD) are moving lower in pre-market trading after Express Scripts (ESRX) spokesman Brian Henry told CNBC's Meg Tirrell and other news outlets that the pharmacy benefits manger will exclusively offer AbbVie's (ABBV) recently approved hepatitis C regimen Viekira Pak at a "significant discount" starting Jan. 1. Express Scripts will no longer offer competing drugs from Gilead and Johnson & Johnson (JNJ). Shares of AbbVie are rising 6% to $71.50 in pre-market trading while Gilead is down 4% to $104.15. AbbVie discovered part of the Viekira Pak regimen via its ongoing collaboration with Enanta Pharmaceuticals (ENTA). Shares of Enanta are up 7% to $49.96 in pre-open trading.
05:44 EDTESRXExpress Scripts to offer AbbVie hepatitis C drug exclusively, CNBC reports
Express Scripts (ESRX) will offer AbbVie's (ABBV) just approved hepatitis C regimen Viekira Pak at a "significant discount" starting Jan. 1, while excluding competing drugs from Gilead (GILD) and Johnson & Johnson (JNJ), CNBC's Meg Tirrell reports, citing comments from the pharmacy benefits manager's spokesman Brian Henry. Reference Link
December 17, 2014
10:51 EDTCI, CNC, MOHLeerink healthcare services analyst holds analyst/industry conference call
Healthcare Services Analyst Gupte provides outlook and favorite names for 2015 in the Hospitals and Managed Care Industry on an Analyst/Industry conference call to be held on December 18 at 1 pm.
December 16, 2014
08:22 EDTESRXExpress Scripts CFO change a 'modest' concern, says Leerink
Subscribe for More Information
08:13 EDTCNCCentene price target raised to $125 from $108 at Cantor
Subscribe for More Information
07:57 EDTCNCCentene price target raised to $118 from $102 at Credit Suisse
Subscribe for More Information
07:47 EDTESRXExpress Scripts new CFO experience reassuring, says Oppenheimer
Subscribe for More Information
December 15, 2014
16:40 EDTESRXExpress Scripts backs FY14 EPS view $4.86-$4.90, consensus $4.88
Subscribe for More Information
16:39 EDTESRXExpress Scripts increases share repurchase authorization by 65M shares
Subscribe for More Information
16:37 EDTESRXExpress Scripts CFO Cathy Smith leaving company
Subscribe for More Information
08:41 EDTCNCCentene price target raised to $120 from $100 at Leerink
Subscribe for More Information
07:40 EDTWLP, ESRXExpress Scripts price target raised to $96 from $82 at UBS
Subscribe for More Information
December 12, 2014
06:06 EDTCNCCentene sees FY15 EPS $5.05-$5.35, consensus $4.92
Sees FY15 premium and service revenues $20.3B-$20.8B.
06:05 EDTCNCCentene backs FY14 EPS view of $4.35-$4.50, consensus $4.28
Subscribe for More Information
December 10, 2014
14:45 EDTWLP, MOH, CNC, CIDeal would block payments to health insurance companies, The Hill says
Subscribe for More Information
December 9, 2014
10:31 EDTCNCCentene to host investor meeting
Subscribe for More Information
December 8, 2014
16:08 EDTMOHMolina Healthcare awarded contract to administer Puerto Rico’s Medicaid program
Subscribe for More Information
11:30 EDTESRXLeerink generics pharmaceutical analyst holds analyst/industry conference call
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use